financetom
Business
financetom
/
Business
/
Legend Biotech Q3 Adjusted Loss Narrows, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Legend Biotech Q3 Adjusted Loss Narrows, Revenue Rises
Nov 12, 2025 4:44 AM

07:17 AM EST, 11/12/2025 (MT Newswires) -- Legend Biotech ( LEGN ) reported a Q3 adjusted net loss Wednesday of $0.05 per diluted share, compared with a loss of $0.11 a year earlier.

Revenue for the quarter ended Sept. 30 was $272.3 million, compared with $160.2 million a year earlier.

Analysts polled by FactSet expected $274.4 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved